Diffuse large B-cell lymphoma (LCGBD) corresponds to the most common lymphoma subtype. With R-CHOP regimen about two-thirds of the patients are cured. Objective: The study aims to show clinical characteristics and survival with the RCHOP regimen in patients with LCGBD. Methods: The study is retrospective involving 80 patients with LCGBD diagnosed in the medical Oncology service of the Hospital Edgardo Rebagliati Martins from 2010 to 2012. Descriptive statistics and the Kaplan Meyer analysis were used to determine the overall survival. Results: 80 patients entered the study, the majority were over 60 years old (68%); female in 52%, ECOG 0/1 was present in 66% of the cases; early stages were the majority of cases (57%); the extranodal compr...
Diffuse Large B-Cell Lymphomas (DLBCL) corresponds to 50% of non-Hodgkin’s lymphomas (LNH). Their tr...
Introduction: Diffuse Large B Cell Lymphoma (DLBCL) is a heterogenous disease. Factors based on clin...
Trabalho Final do Mestrado Integrado em Medicina apresentado à Faculdade de MedicinaMantle cell lymp...
Non-Hodgkin’s lymphomas are common and comprise a heterogeneous group of neoplasms, with diffuse lar...
Linfoma de células grandes B difuso (LCGBD) corresponde a l subtipo de linfoma más frecuente. Con ré...
Pacientes com linfoma difuso de grande célula B (LDGCB) do mesmo grupo de risco pelos critérios do Í...
Se realizó un estudio observacional, descriptivo y retrospectivo para evaluar las características cl...
INTRODUÇÃO: O linfoma difuso de grandes células B, sem outras especificaçoes (LDGCB, SOE) é uma neop...
El linfoma difuso de células B grandes (LDCBG), laforma más común de linfoma no...
ntroduction: chronic lymphocytic leukemia is a malignant proliferative disorder of mature, incompete...
Objective: To determine the epidemiological, clinical and pathological characteristics of lymphoma c...
Background: Diffuse large B cell lymphoma (DLBCL) is one of the most common types of non-Hodgkin's l...
Patients with diffuse large B-cell lymphoma treated in a University Hospital were studied from 1990 ...
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's lymphoma (NHL), accou...
Introducción: El índice linfocito/monocito (ILM) ha sido descrito como un parámetro inflamatorio pro...
Diffuse Large B-Cell Lymphomas (DLBCL) corresponds to 50% of non-Hodgkin’s lymphomas (LNH). Their tr...
Introduction: Diffuse Large B Cell Lymphoma (DLBCL) is a heterogenous disease. Factors based on clin...
Trabalho Final do Mestrado Integrado em Medicina apresentado à Faculdade de MedicinaMantle cell lymp...
Non-Hodgkin’s lymphomas are common and comprise a heterogeneous group of neoplasms, with diffuse lar...
Linfoma de células grandes B difuso (LCGBD) corresponde a l subtipo de linfoma más frecuente. Con ré...
Pacientes com linfoma difuso de grande célula B (LDGCB) do mesmo grupo de risco pelos critérios do Í...
Se realizó un estudio observacional, descriptivo y retrospectivo para evaluar las características cl...
INTRODUÇÃO: O linfoma difuso de grandes células B, sem outras especificaçoes (LDGCB, SOE) é uma neop...
El linfoma difuso de células B grandes (LDCBG), laforma más común de linfoma no...
ntroduction: chronic lymphocytic leukemia is a malignant proliferative disorder of mature, incompete...
Objective: To determine the epidemiological, clinical and pathological characteristics of lymphoma c...
Background: Diffuse large B cell lymphoma (DLBCL) is one of the most common types of non-Hodgkin's l...
Patients with diffuse large B-cell lymphoma treated in a University Hospital were studied from 1990 ...
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's lymphoma (NHL), accou...
Introducción: El índice linfocito/monocito (ILM) ha sido descrito como un parámetro inflamatorio pro...
Diffuse Large B-Cell Lymphomas (DLBCL) corresponds to 50% of non-Hodgkin’s lymphomas (LNH). Their tr...
Introduction: Diffuse Large B Cell Lymphoma (DLBCL) is a heterogenous disease. Factors based on clin...
Trabalho Final do Mestrado Integrado em Medicina apresentado à Faculdade de MedicinaMantle cell lymp...